Us Atherectomy Devices Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

Atherectomy devices are mechanical instruments designed to excise or ablate atherosclerotic plaque from blood vessels, offering an alternative to balloon angioplasty and stenting. The North American segment commands the largest global share, buoyed by advanced healthcare infrastructure, high procedure volumes, and strong physician adoption rates.

• •Market valued at approximately $1.05 billion in 2025 with 7.01% annual growth trajectory
• •Primarily used in peripheral artery disease and coronary interventions across hospitals and specialized clinics
• •Regulated as Class II or III medical devices under FDA oversight, ensuring rigorous safety and efficacy standards

The rising incidence of peripheral artery disease and coronary artery disease, linked to diabetes, obesity, and sedentary lifestyles, directly increases demand for atherectomy procedures. Expanding insurance coverage and favorable reimbursement policies for atherectomy have made these interventions more accessible to patients across diverse socioeconomic groups.

• •Prevalence of lifestyle-related cardiovascular conditions increasing across the United States and Canada
• •Clinical evidence demonstrating reduced procedural complications compared to conventional methods
• •Ongoing FDA approvals for next-generation devices supporting broader clinical indications

The market is segmented by device type, including directional atherectomy, rotational atherectomy, orbital atherectomy, and laser atherectomy systems, with each serving distinct clinical needs. The United States dominates the regional landscape due to its concentration of leading medical device manufacturers, well-established hospital networks, and higher per-capita healthcare spending compared to Canada and Mexico.

• •Directional and orbital atherectomy systems account for the largest product category share
• •United States represents the majority of North American market value, with Canada as a secondary growth market
• •Ambulatory surgical centers and catheterization labs are expanding as procedure sites alongside traditional hospitals

What are the recent trends and outlook?

Emerging trends include the integration of atherectomy with intravascular imaging to improve procedural precision and the development of drug-coated devices to reduce restenosis rates. As the market approaches a compound growth path through 2030, consolidation among mid-tier manufacturers and pipeline advancements in smaller-vessel devices are expected to reshape competitive dynamics.

• •Hybrid procedures combining atherectomy with imaging guidance gaining clinical acceptance
• •Strategic mergers and acquisitions accelerating as larger firms seek to expand product portfolios
• •Growth supported by continued clinical evidence generation and broadening physician adoption across North American healthcare systems